Yang Xiaodong, Xu Wei, Wang Yuji, Tian Jiaxin
Center for Medical Device Evaluation, CFDA, Beijing, 100081.
Zhongguo Yi Liao Qi Xie Za Zhi. 2018 Jul 30;42(4):286-288. doi: 10.3969/j.issn.1671-7104.2018.04.016.
Under the precondition of ensuring safety and effectiveness, whether to reuse reprocessed medical devices to reduce the medical expenses has become the focus of the relevant regulatory authorities in our country. In this paper, we studied the regulatory policy for reprocessed medical devices in major international economies, such as United States, Japan, European Union and so on. From the regulatory and technical level, we thought about the risks of supervising reprocessed medical devices, and analyzed the ideas and risk concerns of supervising reprocessed medical devices to provide reference for regulation of such devices in our country.
在确保安全和有效性的前提下,是否复用经再处理的医疗器械以降低医疗费用已成为我国相关监管部门关注的焦点。本文研究了美国、日本、欧盟等主要国际经济体对经再处理医疗器械的监管政策。从监管和技术层面思考了监管经再处理医疗器械的风险,并分析了监管经再处理医疗器械的思路及风险关注点,为我国此类器械的监管提供参考。